These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2820052)

  • 21. Effect of metabolic depletion on the furosemide-sensitive Na and K fluxes in human red cells.
    Dagher G; Brugnara C; Canessa M
    J Membr Biol; 1985; 86(2):145-55. PubMed ID: 2993628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypokalemia, high erythrocyte Na+ and low erythrocyte Na,K-ATPase in relatives of patients dying from sudden unexplained death syndrome in north-east Thailand and in survivors from near-fatal attacks.
    Tosukhowong P; Chotigasatit C; Tungsanga K; Sriboonlue P; Pansin P; Sitprija V
    Am J Nephrol; 1996; 16(5):369-74. PubMed ID: 8886172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Na,K-ATPase activity reduces Babesia gibsoni infection of canine erythrocytes with inherited high K, low Na concentrations.
    Yamasaki M; Takada A; Yamato O; Maede Y
    J Parasitol; 2005 Dec; 91(6):1287-92. PubMed ID: 16539007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of erythrocyte (Na(+)-K+) ATPase activities in non-insulin-dependent diabetic patients with hyperkalemia.
    Mimura M; Makino H; Kanatsuka A; Yoshida S
    Metabolism; 1992 Apr; 41(4):426-30. PubMed ID: 1313528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement by bioluminescence technique of erythrocyte membrane Na+,K+-ATPase activity in hypertensive patients.
    Lechi C; Corradini P; Polignano R; Bonadonna G; Delva P; Lechi A
    Clin Chim Acta; 1987 Mar; 163(3):329-37. PubMed ID: 3034452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical studies on assay for Na-K ATPase in human blood cells. I. Erythrocyte Na-K ATPase assay in patients with thyroid dysfunction and in those with chronic renal failure].
    Ogasawara H; Nishikawa M
    Nihon Naibunpi Gakkai Zasshi; 1988 May; 64(5):329-39. PubMed ID: 2842203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythrocyte membrane sodium transport in patients with treated and untreated essential hypertension.
    Cole CH
    Circulation; 1983 Jul; 68(1):17-22. PubMed ID: 6303625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the erythrocyte sodium pump altered in human obesity?
    Simat BM; Mayrand RR; From AH; Morley JE; Billington C; Fullerton DS; Ahmed K
    J Clin Endocrinol Metab; 1983 May; 56(5):925-9. PubMed ID: 6300177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients.
    Djemli-Shipkolye A; Gallice P; Coste T; Jannot MF; Tsimaratos M; Raccah D; Vague P
    Metabolism; 2000 Jul; 49(7):868-72. PubMed ID: 10909997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Na,K-ATPase activity in red blood cells from patients with Chediak-Higashi syndrome.
    Proverbio T; Proverbio F; Marín R; Merino F
    Exp Mol Pathol; 1995 Jun; 62(3):173-9. PubMed ID: 8612721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Red cell ouabain binding sites, Na+K+-ATPase, and intracellular Na+ as individual characteristics.
    Schmalzing G; Pfaff E; Breyer-Pfaff U
    Life Sci; 1981 Jul; 29(4):371-81. PubMed ID: 6268910
    [No Abstract]   [Full Text] [Related]  

  • 32. [Determination of human erythrocyte membrane Na+/K(+)-ATPase activity in small volume of blood sample].
    Teraoka K; Miyagoshi M; Fujikawa K; Odajima S; Sugita T; Asaji T; Matsui S; Tsuritani I; Honda R; Yamada Y
    Rinsho Byori; 1992 Apr; 40(4):410-6. PubMed ID: 1317473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythrocyte Na+,K(+)-ATPase properties and adenylate energy charge in normotensives and in essential hypertensives.
    Canestrari F; Galli F; Boschi S; Albertini MC; Gheller G; De Crescentini S; Bossú M
    Clin Chim Acta; 1994 Jan; 224(2):167-79. PubMed ID: 8004787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Kinetic properties of Na+, K+ activated, Mg2+ -dependent ATP-hydrolysis of blood lymphocytes in patients with rheumatoid arthritis and ankylosing spondyloarthritis].
    Fafula RV; Iefremova UP; Lychkovs'ka NE; Vorobets' ZD
    Ukr Biokhim Zh (1999); 2012; 84(3):44-54. PubMed ID: 22860401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythrocyte Na+/K+ ATPase activity measured with 23Na NMR.
    Ouwerkerk R; van Echteld CJ; Staal GE; Rijksen G
    Magn Reson Med; 1989 Nov; 12(2):164-71. PubMed ID: 2559285
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of alteration of sodium potassium pump of erythrocytes from patients with chronic renal failure.
    Cheng JT; Kahn T; Kaji DM
    J Clin Invest; 1984 Nov; 74(5):1811-20. PubMed ID: 6094614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functionally abnormal Na+-K+ pump in erythrocytes of a morbidly obese patient.
    DeLuise M; Flier JS
    J Clin Invest; 1982 Jan; 69(1):38-44. PubMed ID: 6274916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypothesis: low Na/K-ATPase activity in the red cell membrane, a potential marker of the predisposition to diabetic neuropathy.
    Raccah D; Gallice P; Pouget J; Vague P
    Diabete Metab; 1992; 18(3):236-41. PubMed ID: 1327887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of aldose reductase inhibitor (Ponalrestat) on erythrocyte Na,K-ATPase activity in non-insulin-dependent diabetic patients with polyneuropathy.
    Umeda F; Noda K; Hashimoto T; Yamashita T; Nawata H
    Diabetes Res; 1989 Nov; 12(3):125-9. PubMed ID: 2561396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of age on red cell membrane sodium -potassium dependent adenosine triphosphatase (Na+-K+ ATPase) activity in healthy men.
    Gambert SR; Duthie EH
    J Gerontol; 1983 Jan; 38(1):23-5. PubMed ID: 6294172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.